Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LILRA4 Protein (His tag)

LILRA4 Origin: Human Host: HEK-293 Cells Recombinant 90 %
Catalog No. ABIN7489015
  • Target See all LILRA4 Proteins
    LILRA4 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 4 (LILRA4))
    Protein Type
    Recombinant
    Origin
    • 6
    • 1
    Human
    Source
    • 3
    • 2
    • 2
    HEK-293 Cells
    Purification tag / Conjugate
    This LILRA4 protein is labelled with His tag.
    Purpose
    Human LILRA4 / CD85g / ILT7 Protein, His Tag
    Sequence
    Glu 24 - Asn 446
    Characteristics
    Human LILRA4 Protein, His Tag is expressed from human 293 cells (HEK293). It contains AA Glu 24 - Asn 446 (Accession # P59901-1).
    Purity
    90 %
    Endotoxin Level
    1.0 EU per μg
    Top Product
    Discover our top product LILRA4 Protein
  • Comment

    This protein carries a polyhistidine tag at the C-terminus. (10xHis) The protein has a calculated MW of 48.5 kDa. The protein migrates as 60-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Storage
    -20 °C
    Storage Comment
    -20°C
  • Target
    LILRA4 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 4 (LILRA4))
    Alternative Name
    LILRA4 (LILRA4 Products)
    Synonyms
    ILT7 Protein, CD85g Protein, leukocyte immunoglobulin like receptor A4 Protein, LILRA4 Protein
    Background
    Leukocyte immunoglobulin-like receptor subfamily A member 4 (LILRA4/ILT7/CD85g) is a marker of plasmacytoid dendritic cells (pDCs), which are reported to be a major source of the abnormally high levels of IFNα associated with autoimmune diseases. Targeting LILRA4 with therapeutic antibodies to promote killing of these IFNα-producing pDCs is being investigated as a novel approach to alleviating the symptoms of autoimmune diseases. LILRA4 is an immunoglobulin-like protein preferentially expressed on the surface of human plasmacytoid dendritic cells (pDCs). It interacts with bone marrow stromal cell antigen 2 to control the Toll-like receptor (TLR) driven response by pDCs to viral infection. It may also be involved in modulating pDC-tumour interactions. pDCs are a source of the excess IFNα which drives autoimmune disease symptoms.
    Molecular Weight
    48.5 kDa
You are here: